Urinary Versus Recombinant Gonadotropins for Ovarian Stimulation in Women Undergoing Treatment with Assisted Reproductive Technology

Globally, about 10%–15% couples are affected by infertility, with major role being played by the couple's lifestyle. Several gonadotropin preparations (urinary, purified urinary, recombinant, and biosimilars) are available for use. Purified urinary formulations offer numerous advantages over th...

Descripción completa

Detalles Bibliográficos
Autores principales: Patki, Ameet, Bavishi, Himanshu, Kumari, Chandravati, Kamraj, Jayarani, Venugopal, M., Kunjimoideen, K. U., Nadkarni, Poornima, Sankari, Samundi, Chaudhary, Sunil, Sangeeta, M. J., Manjunath, C. S., Kumar, Pratap
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094533/
https://www.ncbi.nlm.nih.gov/pubmed/30158806
http://dx.doi.org/10.4103/jhrs.JHRS_79_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094533/
https://www.ncbi.nlm.nih.gov/pubmed/30158806
http://dx.doi.org/10.4103/jhrs.JHRS_79_17

Ejemplares similares